Medicare Excludes Coverage for High-Cost Obesity Drugs Under CMS Policy
The Trump administration's CMS decision excludes costly obesity treatments from Medicare coverage, highlighting challenges in drug pricing and healthcare policy reforms.
The Trump administration's CMS decision excludes costly obesity treatments from Medicare coverage, highlighting challenges in drug pricing and healthcare policy reforms.
CMS has indefinitely suspended federally funded nursing home ownership reporting due to PECOS system issues, delaying the revalidation deadline and advising ongoing data collection. Key updates on regulatory compliance for Medicare and Medicaid providers.
Dr. Oz's tenure at the Centers for Medicare & Medicaid Services has drawn positive reviews, highlighting changes in Medicare and Medicaid policy management.
Explore the challenges faced by a city in implementing retiree health insurance cost shifts, including delayed state reimbursements and budget impacts amid fiscal pressures.
Sumter YMCA provides a free Medicare Diabetes Prevention Program to help seniors with prediabetes adopt healthier lifestyles and reduce type 2 diabetes risk.
Jamie P. McNamara sentenced to 10 years for defrauding Medicare of $174 million through a genetic testing scheme involving telemarketing and fake doctor orders. Federal investigations by HHS-OIG and the FBI led to recovery and prosecution under the Health Care Fraud Strike Force.
Explore key trends in Medicare beneficiary growth and state-by-state payout variations, including health risk disparities and emergency room utilization patterns affecting U.S. insurance and healthcare markets.
Analyze Medicare beneficiary growth and state-level spending with insights on senior health risks, ER visits, and inpatient services across the U.S.
CMS launches MAHA ELEVATE and ACCESS models to promote lifestyle medicine and value-based care in Medicare, focusing on chronic disease management and cost reduction.
Detailed analysis of 2025 skilled nursing sector challenges including deregulation impacts, Medicaid funding cuts, private equity roles, and market trends driving nursing home valuations and closures.